T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1026
Advance Auto Parts
AAP
$3.23B
| $11.5M | ﹤0.01% |
77,980
-338
| -0.4% | -$54.7K |
|
1027
iShares MSCI India ETF
INDA
$6.58B
| $11.4M | ﹤0.01% |
272,872
-2,800
| -1% | -$119K |
|
1028
Dynatrace
DT
$14.3B
| $11.2M | ﹤0.01% |
291,678
+5,099
| +2% | +$185K |
|
1029
Zions Bancorporation
ZION
$10.5B
| $11.2M | ﹤0.01% |
226,892
-352
| -0.2% | -$17.6K |
|
|
LUXE
1030
LuxExperience B.V.
LUXE
$1.09B
| $11.1M | ﹤0.01% |
1,247,962
-15,228
| -1% | -$157K |
|
|
NVRO
1031
DELISTED
NEVRO CORP.
NVRO
| $11.1M | ﹤0.01% |
280,434
-10,099
| -3% | -$420K |
|
1032
Certara
CERT
$1.24B
| $11.1M | ﹤0.01% |
689,248
-268,337
| -28% | -$3.89M |
|
1033
F5
FFIV
$24B
| $10.9M | ﹤0.01% |
76,255
-1,700
| -2% | -$249K |
|
1034
NRG Energy
NRG
$25.4B
| $10.9M | ﹤0.01% |
343,138
-1,952
| -0.6% | -$77.2K |
|
1035
Genmab
GMAB
$19.3B
| $10.6M | ﹤0.01% |
251,098
-1,100
| -0.4% | -$45.3K |
|
1036
American Airlines Group
AAL
$9.97B
| $10.6M | ﹤0.01% |
835,301
+7,606
| +0.9% | +$103K |
|
1037
FIVE9
FIVN
$2.53B
| $10.6M | ﹤0.01% |
156,344
-1,719,842
| -92% | -$108M |
|
1038
LCI Industries
LCII
$2.6B
| $10.6M | ﹤0.01% |
114,724
-39,863
| -26% | -$3.91M |
|
1039
Reinsurance Group of America
RGA
$16.1B
| $10.5M | ﹤0.01% |
74,218
+36,923
| +99% | +$5.16M |
|
1040
W.P. Carey
WPC
$16.1B
| $10.5M | ﹤0.01% |
137,764
+22,236
| +19% | +$1.67M |
|
|
ALLK
1041
DELISTED
Allakos
ALLK
| $10.5M | ﹤0.01% |
1,250,433
+451,058
| +56% | +$3.13M |
|
1042
FTI Consulting
FCN
$4.24B
| $10.5M | ﹤0.01% |
66,072
-27,286
| -29% | -$4.55M |
|
1043
Hasbro
HAS
$13.4B
| $10.5M | ﹤0.01% |
171,625
-2,207
| -1% | -$138K |
|
1044
Arcus Biosciences
RCUS
$3.67B
| $10.5M | ﹤0.01% |
505,747
+481,848
| +2,016% | +$13.3M |
|
1045
Whirlpool
WHR
$2.79B
| $10.4M | ﹤0.01% |
73,636
-437
| -0.6% | -$62.1K |
|
1046
Brunswick
BC
$5.21B
| $10.3M | ﹤0.01% |
143,057
-9,885
| -6% | -$703K |
|
|
DCPH
1047
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $10.2M | ﹤0.01% |
624,887
-91,870
| -13% | -$1.49M |
|
1048
Prestige Consumer Healthcare
PBH
$2.43B
| $10.2M | ﹤0.01% |
163,218
+111,046
| +213% | +$6.37M |
|
1049
Carnival Corporation Ltd
CCL
$38.9B
| $10.2M | ﹤0.01% |
1,264,656
+12,533
| +1% | +$108K |
|
1050
Gibraltar Industries
ROCK
$1.46B
| $10.1M | ﹤0.01% |
220,055
-51,949
| -19% | -$2.49M |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.